Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant

• Κύριοι συγγραφείς: Stéphanie Baillif (Συγγραφέας), Pascal Staccini (Συγγραφέας), Michel Weber (Συγγραφέας), Marie-Noëlle Delyfer (Συγγραφέας), Yannick Le Mer (Συγγραφέας), Vincent Gualino (Συγγραφέας), Laurence Collot (Συγγραφέας), Pierre-Yves Merite (Συγγραφέας), Catherine Creuzot-Garcher (Συγγραφέας), Laurent Kodjikian (Συγγραφέας), Pascale Massin (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2022-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

To assess anatomical and functional outcomes after switching from dexamethasone implant (DEXi) to fluocinolone acetonide implant (FAci) in 113 diabetic macular edema eyes, a multicentric retrospective observational study was conducted. Seventy-five eyes (73.5%) were switched 1-8 weeks after their la...